Clinical Trials in New York State

Showing 3821-3840 of 8,190 trials

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

NCT01002820

This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.

Epilepsy, Complex Partial

Marinus Pharmaceuticals11 participantsStarted Oct 2009

Los Angeles, California, United States • Lexington, Kentucky, United States • Albany, New York, United States +4 more locations

COMPLETEDPhase 294 miles

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

NCT03889886

SDP-4-CS201, is a Phase 2, multi-center, double-masked, randomized, vehicle-controlled, dose-response, parallel-group study designed to evaluate the ocular and systemic safety and efficacy of SDP-4 ophthalmic solution in subjects with moderate to severe dry eye disease over a 12-week treatment period. Three concentrations (0.1%, 1.0% and 3.0%) of SDP-4 ophthalmic solution will be given to parallel groups via topical ocular instillation BID.

Dry Eye

Silk Technologies, Ltd.305 participantsStarted Apr 2019

Azusa, California, United States • Garden Grove, California, United States • Mission Hills, California, United States +23 more locations

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

Find Trials by Condition in New York State

Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

A Trial of LY3056480 in Patients With SNLH

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Lenalidomide Monotherapy in R/R DLBCL

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

Platelet Rich Plasma (PRP) in Total Knee Replacement

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours